The Causal Role of Cigarette Smoking in Bladder Cancer Initiation and Progression, and the Role of Urologists in Smoking Cessation

Journal of Urology

Volumn 180, Issue 1, 2008, Pages 31-37

  Strope, Seth A ^a   Montie, James E ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

bladder; bladder neoplasms; epidemiology; physician patient relations; smoking

Indexed keywords

BLADDER CANCER; CANCER RISK; CIGARETTE SMOKING; DOCTOR PATIENT RELATION; GENETIC RISK; HUMAN; MEDICAL LITERATURE; MEDLINE; PATIENT COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; SMOKING CESSATION;

ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S ROLE; RISK FACTORS; SMOKING; SMOKING CESSATION; URINARY BLADDER NEOPLASMS; UROLOGY;

EID: 44649085568     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.03.045     Document Type: Review

References (53)

1. Windish D.M., Huot S.J., and Green M.L. Medicine residents' understanding of the biostatistics and results in the medical literature. JAMA 298 (2007) 1010
2. Nieder A.M., John S., Messina C.R., Granek I.A., and Adler H.L. Are patients aware of the association between smoking and bladder cancer?. J Urol 176 (2006) 2405
3. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43
4. Botteman M.F., Pashos C.L., Redaelli A., Laskin B., and Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 21 (2003) 1315
5. Messing E.M. Urothelial tumors of the urinary tract. In: Walsh P.C., Retik A.B., Vaughan Jr. E.D., and Wein A.J. (Eds). Campbell's Urology. 8th ed. (2002), WB Saunders Co, Philadelphia 2732-2784 vol 4
6. Cohen S.M., and Johansson S.L. Epidemiology and etiology of bladder cancer. Urol Clin North Am 19 (1992) 421
7. Walter S.D. A generalization of a matrix occupancy problem. Biometrics 32 (1976) 471
8. Greenland S., and Rothman K.J. Measures of effect and measures of association. In: Rothman K.J., and Greenland S. (Eds). Modern Epidemiology. 2nd ed. (1998), Lippincott Williams, Philadelphia 47-64
9. Rothman K.J. Epidemiology: An Introduction (2002), Oxford University Press, New York 53-55
10. Howe G.R., Burch J.D., Miller A.B., Cook G.M., Esteve J., Morrison B., et al. Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst 64 (1980) 701
11. Hartge P., Silverman D., Hoover R., Schairer C., Altman R., Austin D., et al. Changing cigarette habits and bladder cancer risk: a case-control study. J Natl Cancer Inst 78 (1987) 1119
12. Zeegers M.P., Goldbohm R.A., and van denBrandt P.A. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Cancer Causes Control 13 (2002) 83
13. Puente D., Hartge P., Greiser E., Cantor K.P., King W.D., Gonzalez C.A., et al. A pooled analysis of bladder cancer case-control studies evaluating smoking in men and women. Cancer Causes Control 17 (2006) 71
14. Rothman K.J., and Greenland S. Modern Epidemiology. 2nd ed. (1998), Lippincott Williams, Philadelphia
15. Castelao J.E., Yuan J.M., Skipper P.L., Tannenbaum S.R., Gago-Dominguez M., Crowder J.S., et al. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 93 (2001) 538
16. Zeegers M.P., Tan F.E., Dorant E., and van Den Brandt P.A. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 88 (2000) 630
17. Health Evidence Network (HEN): Smoking prevalence in adults (%), 1994-1998 and 1999-2001. http://www.euro.who.int/HEN/Syntheses/tobcontrol/20030823_1 Accessed March 4, 2008
18. Brennan P., Bogillot O., Cordier S., Greiser E., Schill W., Vineis P., et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 86 (2000) 289
19. Mendez D., Warner K.E., and Courant P.N. Has smoking cessation ceased?. Expected trends in the prevalence of smoking in the United States. Am J Epidemiol 148 (1998) 249
20. Cigarette smoking among adults-United States, 2004. MMWR Morb Mortal Wkly Rep 54 (2005) 1121
21. Brennan P., Bogillot O., Greiser E., Chang-Claude J., Wahrendorf J., Cordier S., et al. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control 12 (2001) 411
22. Bjerregaard B.K., Raaschou-Nielsen O., Sorensen M., Frederiksen K., Tjonneland A., Rohrmann S., et al. The effect of occasional smoking on smoking-related cancers in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 17 (2006) 1305
23. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General (2006), United States Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta
24. Alberg A.J., Kouzis A., Genkinger J.M., Gallicchio L., Burke A.E., Hoffman S.C., et al. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke. Am J Epidemiol 165 (2007) 660
25. Jiang X., Yuan J.M., Skipper P.L., Tannenbaum S.R., and Yu M.C. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res 67 (2007) 7540
26. Lin J., Spitz M.R., Dinney C.P., Etzel C.J., Grossman H.B., and Wu X. Bladder cancer risk as modified by family history and smoking. Cancer 107 (2006) 705
27. Cao W., Cai L., Rao J.Y., Pantuck A., Lu M.L., Dalbagni G., et al. Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer 104 (2005) 2400
28. Garcia-Closas M., Malats N., Real F.X., Welch R., Kogevinas M., Chatterjee N., et al. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 15 (2006) 536
29. Kader A.K., Shao L., Dinney C.P., Schabath M.B., Wang Y., Liu J., et al. Matrix metalloproteinase polymorphisms and bladder cancer risk. Cancer Res 66 (2006) 11644
30. Gormally E., Vineis P., Matullo G., Veglia F., Caboux E., Le Roux E., et al. TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study. Cancer Res 66 (2006) 6871
31. Sak S.C., Barrett J.H., Paul A.B., Bishop D.T., and Kiltie A.E. Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 15 (2006) 2537
32. Garcia-Closas M., Malats N., Silverman D., Dosemeci M., Kogevinas M., Hein D.W., et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366 (2005) 649
33. Rockhill B. Theorizing about causes at the individual level while estimating effects at the population level: implications for prevention. Epidemiology 16 (2005) 124
34. Pepe M.S., Janes H., Longton G., Leisenring W., and Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159 (2004) 882
35. Fleshner N., Garland J., Moadel A., Herr H., Ostroff J., Trambert R., et al. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 86 (1999) 2337
36. Aveyard P., Adab P., Cheng K.K., Wallace D.M., Hey K., and Murphy M.F. Does smoking status influence the prognosis of bladder cancer?. A systematic review. BJU Int 90 (2002) 228
37. Chen C.H., Shun C.T., Huang K.H., Huang C.Y., Tsai Y.C., Yu H.J., et al. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU Int 100 (2007) 281
38. Ostroff J., Garland J., Moadel A., Fleshner N., Hay J., Cramer L., et al. Cigarette smoking patterns in patients after treatment of bladder cancer. J Cancer Educ 15 (2000) 86
39. Centers for Disease Control and Prevention (CDC). Tobacco use among adults-United States, 2005. MMWR Morb Mortal Wkly Rep 55 (2006) 1145
40. Dresler C.M., Leon M.E., Straif K., Baan R., and Secretan B. Reversal of risk upon quitting smoking. Lancet 368 (2006) 348
41. Anthonisen N.R., Skeans M.A., Wise R.A., Manfreda J., Kanner R.E., Connett J.E., et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 142 (2005) 233
42. Vogt F., Hall S., and Marteau T.M. General practitioners' beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies. BMC Public Health 6 (2006) 277
43. Tong E.K., Ong M.K., Vittinghoff E., and Perez-Stable E.J. Nondaily smokers should be asked and advised to quit. Am J Prev Med 30 (2006) 23
44. Thorndike A.N., Rigotti N.A., Stafford R.S., and Singer D.E. National patterns in the treatment of smokers by physicians. JAMA 279 (1998) 604
45. Dearing J. Disease-centred advice for patients with superficial transitional cell carcinoma of the bladder. Ann R Coll Surg Engl 87 (2005) 85
46. Vogt F., Hall S., and Marteau T.M. General practitioners' and family physicians' negative beliefs and attitudes towards discussing smoking cessation with patients: a systematic review. Addiction 100 (2005) 1423
47. Ferreira-Borges C. Effectiveness of a brief counseling and behavioral intervention for smoking cessation in pregnant women. Prev Med 41 (2005) 295
48. Kottke T.E., Brekke M.L., Solberg L.I., and Hughes J.R. A randomized trial to increase smoking intervention by physicians. Doctors Helping Smokers, Round I. JAMA 261 (1989) 2101
49. Bao Y., Duan N., and Fox S.A. Is some provider advice on smoking cessation better than no advice?. An instrumental variable analysis of the 2001 National Health Interview Survey. Health Serv Res 41 (2006) 2114
50. Silagy C., Lancaster T., Stead L., Mant D., and Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (2004) CD000146
51. Hughes J., Stead L., and Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev (2004) CD000031
52. Lancaster T., and Stead L.F. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev (2005) CD001292
53. Stead L.F., and Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev (2005) CD001007